Group 1 - The mechanical sector has shown strong performance in 2025, with the Shenwan Mechanical Equipment Index rising by 36.11%, outperforming the Shanghai Composite Index by 19.74 percentage points and the Shenzhen Component Index by 8.78 percentage points [4][16][19] - In the first three quarters of 2025, the mechanical industry reported revenues of 15,135.34 billion yuan, a year-on-year increase of 7.35%, and a net profit attributable to shareholders of 1,080.76 billion yuan, up 16.80% year-on-year [4][22][27] - The public fund allocation ratio for the mechanical equipment sector increased by 0.25 percentage points in Q3 2025 compared to Q3 2024, indicating improved fundamentals and positive policy impacts [29] Group 2 - The equipment manufacturing industry has maintained export resilience, with significant growth in new overseas markets. From January to October 2025, the export delivery value of general equipment, specialized equipment, and transportation equipment reached 6,173.20 billion yuan, 5,319.30 billion yuan, and 4,124 billion yuan respectively, with year-on-year growth rates of 5.5%, 9.3%, and 24.20% [5][33][36] - The overseas sales of engineering machinery continued to grow, with a year-on-year increase of 11.84% in export value from January to October 2025, driven by technological innovation and diversified market strategies [37][41] - The motorcycle industry has established a strong competitive advantage in overseas markets, with exports reaching 1,101.85 million units and 7.278 billion USD in value from January to October 2025, reflecting a year-on-year increase of 22.28% and 28.2% respectively [42][43] Group 3 - The emergence of new manufacturing scenarios signifies a profound transformation from "single technology upgrades" to "systematic ecological restructuring," enhancing production efficiency, product quality, and innovation capabilities [5][46] - Human-shaped robots are expected to address customization challenges in traditional manufacturing, with a market space projected to expand significantly as they transition from industrial applications to household use [47][54] - The intelligent logistics equipment market in China is expected to grow rapidly, with a projected market size of 1,261 billion yuan in 2025, driven by advancements in IoT and AI technologies [64][72]

证券之星消息，12月12日化学制品板块较上一交易日上涨0.28%，侨源股份领涨。当日上证指数报收于 3889.35，上涨0.41%。深证成指报收于13258.33，上涨0.84%。化学制品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 301286 | 侨源股份 | 44.92 | 16.89% | 11.63万 | | 4.96亿 | | 003002 | 壶化股份 | 29.43 | 6.90% | 9.87万 | | 2.87亿 | | 301212 | 联盛化学 | 30.31 | 6.43% | 3.90万 | | 1.16亿 | | 002430 | 杭氢股份 | 30.58 | 6.25% | 33.84万 | | 10.19 亿 | | 000881 | 中广核技 | 9.02 | 5.87% | 71.04万 | | 6.38亿 | | 300741 | 华宇股份 | 18.76 | 5.81% | 6.68万 | | 1.25亿 | | ...

中广核核技术发展股份有限公司 关于公司总经理助理辞职的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 中广核核技术发展股份有限公司（以下简称"公司"）于 2025 年 12 月 2 日 收到公司总经理助理秦波先生提交的书面辞职报告，秦波先生由于个人原因，申 请辞去总经理助理职务，辞职后不在公司任职。根据《公司法》《公司章程》的 有关规定，秦波先生的辞职报告自送达公司董事会之日起生效。截至本公告披露 日，秦波先生未持有公司股份，其持有的公司《股票期权激励计划》授予的 93,334 份股票期权将由董事会注销。秦波先生不存在应当履行而未履行的承诺事项。 证券代码：000881 证券简称：中广核技 公告编号：2025-053 公司董事会对秦波先生在任职期间为公司发展所做出的贡献表示衷心感谢！ 特此公告。 中广核核技术发展股份有限公司 董事会 2025 年 12 月 3 日 ...

AI赋能 核力倍增 核技术应用产业智能化提速 ● 本报记者 刘杨 当规模数千亿元、年均增速超15%的核技术应用产业，与正迈向价值创造阶段的人工智能技术相遇，一 场关乎效率革命、精度突破与场景拓展的产业变革已然发生。 "人工智能+核技术应用已显露出倍增效应，为这一重要引擎赋能增效，有望推动其在国民经济各领域 实现更深层次的融合与突破。"国家原子能机构原副主任、中国核能行业协会特邀专家王毅韧表示。中 国证券报记者通过多方调研发现，昔日高精尖的小众领域，如今正借助AI技术的东风，打破行业边 界、突破技术瓶颈，在安检、食品检测、新能源等多个领域实现创新突破。 智慧安检革新民生体验 AI赋能下的核技术，正以更贴近民生的姿态，渗透到公共安全领域的核心场景。记者调研了解到，过 去传统安检模式效率偏低，旅客需频繁取出电子设备、液体等物品，既耗时又不便，而"AI+核技术"的 融合应用，正彻底改变这一现状。 同方威视为香港国际机场打造的智能保安检查系统，便是这一融合的典型样本。"我们整合了手提行李 CT及智能回框系统、托运行李CT检查系统、毫米波人体安检仪等全套设备，而AI算法则实现了这些设 备的高效协同与智能升级。"同方威视副 ...

Core Insights - The integration of AI and nuclear technology is driving a significant transformation in the nuclear technology application industry, which has a market size of several hundred billion yuan and an annual growth rate exceeding 15% [1] - AI is enhancing the efficiency and precision of nuclear technology applications across various sectors, including public safety, food safety, and new energy [1][5] Group 1: AI and Nuclear Technology in Public Safety - The combination of AI and nuclear technology is revolutionizing traditional security checks, improving efficiency and convenience for travelers [2] - The intelligent security system developed by Tongfang Weishi for Hong Kong International Airport exemplifies this integration, significantly increasing the throughput of security checks from 240 to 360 passengers per hour, a 50% efficiency improvement [2] - The new security solutions are expected to be fully implemented by 2026, allowing travelers to keep liquids and gels in their bags, thus simplifying the security process [2] Group 2: AI and Nuclear Technology in Food Safety - The fusion of AI and nuclear technology is addressing traditional challenges in food safety testing, particularly in non-destructive testing methods [3] - The durian quality CT detection system represents a significant advancement, achieving over 98% accuracy in quality grading, which is 40 times more accurate than manual inspections [3] Group 3: AI and Nuclear Technology in New Energy - In the new energy sector, Tongfang Weishi is utilizing industrial CT imaging technology combined with AI to create a quality assurance system for lithium batteries, capable of identifying micron-level defects [4] - This technology aims to reduce the risk of battery fires and has established partnerships with leading lithium battery manufacturers [4][5] Group 4: Market Expansion and Challenges - The new industrialization efforts in China are creating direct demand and broad market opportunities for nuclear technology applications, particularly in manufacturing upgrades and digital economy development [6] - Challenges such as insufficient industrialization and innovation capabilities, interdisciplinary collaboration issues, and talent shortages need to be addressed for future growth [6] - Key strategic directions include enhancing top-level planning, implementing regulatory frameworks, focusing on technological breakthroughs, and promoting open cooperation [6] Group 5: Key Companies in Nuclear Technology - Tongfang Co., Ltd. (600100) is a leader in security checks, providing solutions that integrate radiation imaging and AI for various applications [8] - China General Nuclear Power Corporation (000881) focuses on non-power nuclear technology applications, including industrial irradiation and medical accelerators [8] - China National Nuclear Corporation (01763.HK) specializes in medical isotopes and nuclear medical equipment, while China Nuclear Power (601985) operates multiple nuclear power plants [8]

11月27日，中广核技涨5.35%，截至发稿，报8.86元/股，成交1.66亿元，换手率2.34%，总市值83.76亿 元。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，南方基金旗下1只基金位居中广核技十大流通股东。南方中证1000ETF（512100）三季度减 持4.36万股，持有股数519.27万股，占流通股的比例为0.62%。根据测算，今日浮盈赚取约233.67万元。 南方中证1000ETF（512100）成立日期2016年9月29日，最新规模766.3亿。今年以来收益23.15%，同类 排名2011/4206；近一年收益22.74%，同类排名2147/4006；成立以来收益8.99%。 南方中证1000ETF（512100）基金经理为崔蕾。 截至发稿，崔蕾累计任职时间7年22天，现任基金资产总规模1227.6亿元，任职期间最佳基金回报 168.04%， 任职期间最差基金回报-15.93%。 资料显示，中广核核技术发展股份有限公司位 ...

Market Overview - The Shanghai Composite Index closed at 3870.02 points, above the six-month moving average, with a gain of 0.87% [1] - The total trading volume of A-shares reached 182.62 billion yuan [1] Stocks Breaking the Six-Month Line - A total of 290 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Xunxing Co., Ltd. (002098) with a deviation rate of 9.03% and a daily increase of 10.04% [1] - Meino Energy (001299) with a deviation rate of 8.16% and a daily increase of 9.98% [1] - Laimu Co., Ltd. (603633) with a deviation rate of 7.83% and a daily increase of 8.70% [1] Detailed Stock Performance - The following stocks have notable performance metrics: - Xunxing Co., Ltd. (002098): Latest price 10.08 yuan, half-year line 9.24 yuan, turnover rate 3.52% [1] - Meino Energy (001299): Latest price 13.00 yuan, half-year line 12.02 yuan, turnover rate 6.41% [1] - Laimu Co., Ltd. (603633): Latest price 10.87 yuan, half-year line 10.08 yuan, turnover rate 7.02% [1] - Other stocks with significant performance include: - Xinhua Pharmaceutical (000756) with a daily increase of 10.00% and a deviation rate of 6.41% [1] - Tonghe Technology (300491) with a daily increase of 7.25% and a deviation rate of 6.40% [1]

Core Viewpoint - The stock of China General Nuclear Power Technology Co., Ltd. (CGN Tech) reached its daily limit up on November 25, 2025, with a closing price of 8.82 yuan, reflecting a 9.98% increase, driven by significant growth in its electronic accelerator business, capital injection into its medical sector, and improvements in governance structure [1][2]. Group 1: Business Performance - The company's core business includes accelerator manufacturing, with a notable 21% year-on-year increase in contract signings for electronic accelerators [2]. - Overseas sales of linear accelerators surged by 75%, indicating strong international demand [2]. - The gross margin for the new materials business increased by 1.5 percentage points, and the proportion of high-margin products rose by 1.7 percentage points [2]. Group 2: Financial and Governance Improvements - The controlling shareholder injected 500 million yuan into a medical technology company to support business development in the healthcare sector [2]. - Financial expenses decreased by 43.91% year-on-year, reflecting improved financial management [2]. - The company has optimized its governance structure by enhancing investor relations, insider information management, and compliance management, including the establishment of a chief legal advisor [2]. Group 3: Market Dynamics - Recent market interest in nuclear technology applications has positively influenced the stock performance of CGN Tech and similar companies, creating a sector-wide effect [2]. - There was a notable inflow of funds into CGN Tech's stock on the day it hit the limit up, contributing to the price surge [2].

从中广核技十大流通股东角度 截至发稿，崔蕾累计任职时间7年20天，现任基金资产总规模1227.6亿元，任职期间最佳基金回报 161.89%， 任职期间最差基金回报-16.88%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，南方基金旗下1只基金位居中广核技十大流通股东。南方中证1000ETF（512100）三季度减 持4.36万股，持有股数519.27万股，占流通股的比例为0.62%。根据测算，今日浮盈赚取约212.9万元。 南方中证1000ETF（512100）成立日期2016年9月29日，最新规模766.3亿。今年以来收益21.59%，同类 排名1964/4206；近一年收益20.2%，同类排名2173/3983；成立以来收益7.6%。 南方中证1000ETF（512100）基金经理为崔蕾。 11月25日，中广核技涨5.11%，截至发稿，报8.43元/股，成交1.22亿元，换手率1.78%，总市值79.70亿 元。 资料显示，中广核核 ...

Core Insights - The article highlights the advancements in proton therapy technology by China General Nuclear Power Group (CGN) and its subsidiary, CGN Medical Technology, which has established the first commercial multi-room proton therapy system production base in China [1] - The 230 MeV cyclotron, a key component of the proton therapy system, has been successfully produced, with three units completed in the first year of operation [1] - The company aims to achieve a world-class nuclear medical industry by 2030, leveraging local research and manufacturing capabilities in Mianyang, Sichuan [1] Company Overview - CGN Medical Technology has adopted a strategy of "introduction, digestion, absorption, and re-innovation" to develop its proton therapy systems, following successful practices in China's nuclear power sector [1] - The proton therapy system consists of 227 main devices and approximately 155,000 components, showcasing its complexity and technological sophistication [1] - The company has formed partnerships with over 80 upstream and downstream enterprises in the industry, promoting continuous technological innovation [1] Industry Context - The Sichuan province has implemented supportive policies to foster the development of the nuclear medical industry, aiming to establish itself as a global leader in medical isotope production and nuclear medical equipment manufacturing by 2030 [1] - The region's strong research and manufacturing foundation, exemplified by institutions like the China Engineering Physics Research Institute, contributes to the rapid growth of the nuclear medical sector in Mianyang [1] - The article emphasizes the potential for China to export its advanced imaging and treatment technologies internationally, marking a significant step in the global nuclear medical landscape [1]